UpGuard's Cyber Security Ratings range from 0 to 950. The higher the score, the more likely Adial is implementing good security practices.
Adial Pharmaceuticals, Inc. ("the Company") is a clinical-stage biopharmaceutical company focused on the development of a therapeutic agent for the treatment of alcohol use disorder ("AUD") using its lead investigational new drug product, AD04, a selective serotonin-3 antagonist (i.e., a "5-HT3 antagonist").
This report shows a preliminary security rating for Adial. UpGuard scans billions of digital assets daily, in depth, across thousands of vectors. Data leak detection, vulnerability scanning and identity breach detection are just some of the advanced capabilities offered by the UpGuard platform.Get a deeper scan →
Read more about the latest issues in cybersecurity
Internet Protocol (IP) attribution is the attempt to identify a device ID or individual responsible ...
Data loss prevention (DLP) is a set of processes and technologies that ensure sensitive data is not ...
Compare Adial's security performance with other companies